Jump to content

Drilldown: Medicines

Choose a table:


Medicines > generic : 1V-LSD or Valsartan

Use the filters below to narrow your results.

generic: (Click arrow to add another value)
brand:
None (1) · Diovan; Entresto (in fixed-dose combination with sacubitril) (1)
classes:
Classic Psychedelic (1) · Lysergamide (1) · Research material (1) · [[:Category:Angiotensin_receptor_blockers|Angiotensin receptor blocker (ARB)]] (1) · [[:Category:Antihypertensives|Antihypertensive]] (1)
mechanism:
Prodrug of LSD; 5-HT2A agonist (1) · '"`UNIQ--vote-000004C8-QINU`"' Largely hepatically cleared (~80% biliary); no active metabolite. Sacubitril-valsartan (Entresto) combines an ARB with neprilysin inhibition for HFrEF and was a notable advance over the ARB-alone trial (PARADIGM-HF, 2014)'"`UNIQ--ref-000004C9-QINU`"'. (1)
uses:
None (1) · '"`UNIQ--vote-000004CA-QINU`"', '"`UNIQ--vote-000004CB-QINU`"', '"`UNIQ--vote-000004CC-QINU`"' (1)
starting dose:
None (1) · 80-160 mg PO once daily (40 mg BID in HFrEF, titrating up to 160 mg BID) (1)
preparations:
None (1) · 40, 80, 160, 320 mg tablets; oral suspension (1)
fda max:
None (1) · 320 mg/d (hypertension); 320 mg/d (HF) (1)
routes:
None (1) · Oral (1)
onset:
None (1) · BP effect 2 hours; max at 4-6 weeks (1)
duration:
None (1) · 24 hours (1)
halflife:
None (1) · ~6 hours'"`UNIQ--ref-000004CD-QINU`"' (1)
bioavailability:
None (1) · ~25% (oral; food reduces absorption ~40%)'"`UNIQ--ref-000004CE-QINU`"' (1)
pregnancy:
None (1) · '''Contraindicated in pregnancy''' (all trimesters); fetal renal injury, oligohydramnios, hypocalvaria, hypotension. Stop on detection'"`UNIQ--ref-000004CF-QINU`"' (1)
legal:
None (1) · [[USLegal:Prescription only|Rx-only]] in US (1)

Showing below up to 2 results in range #1 to #2.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

1


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"